Octagon Capital Advisors LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839435

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 33 positions · Total reported value $624.99M · Top-10 concentration 76.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 65.5% · 2 new · 14 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -23.3% · vs SPY -25.4% · Prev Value $1.11B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -9.9% · vs SPY -12.0% · Latest Value $750.61M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, Octagon Capital Advisors LP disclosed 33 equity positions with a combined reported value of $624.99M. The filing implies a focused portfolio: its ten largest positions account for 76.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were APLS ($168.03M), CBAY ($63.15M), VRNA ($47.10M). By sector, the heaviest allocations are Health Care 43.5%, Other 56.5%. Versus the prior quarter, allocation shifted toward Other (+24.0pp) and away from Health Care (-24.0pp).

Versus the prior quarter, Octagon Capital Advisors LP opened 2 new positions, trimmed 14 and fully exited 3, a turnover rate of 65.5% of positions. The portfolio's overlap with the prior quarter was 49% of names.

The largest new positions opened in Q4 2023 were GPCR ($16.87M), CYTK ($9.68M), RAPT ($7.26M).

Of the 3 positions fully exited versus the prior quarter, the largest were MRTX ($28.53M), ETNB ($18.82M), AMLX ($12.73M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • GPCR STRUCTURE THERAPEUTICS INC · $16.87M
  • CYTK CYTOKINETICS INC · $9.68M
  • RAPT RAPT THERAPEUTICS INC · $7.26M
  • GRCL GRACELL BIOTECHNOLOGIES INC · $5.99M
  • VERU VERU INC · $2.74M
  • ANAB ANAPTYSBIO INC · $2.57M
  • NUVB NUVATION BIO INC · $1.51M
  • MIRM MIRUM PHARMACEUTICALS INC · $738.00K

Fully Exited (vs previous quarter)

  • MRTX MIRATI THERAPEUTICS INC · prev qtr: $28.53M
  • ETNB 89BIO INC · prev qtr: $18.82M
  • AMLX AMYLYX PHARMACEUTICALS INC · prev qtr: $12.73M
  • TSHA TAYSHA GENE THERAPIES INC · prev qtr: $8.78M · history
  • PMVP PMV PHARMACEUTICALS INC · prev qtr: $5.55M
  • VKTX VIKING THERAPEUTICS INC · prev qtr: $4.15M
  • GLUE MONTE ROSA THERAPEUTICS INC · prev qtr: $3.89M
  • VIR VIR BIOTECHNOLOGY INC · prev qtr: $3.05M

Insider Transactions (Form 4)

Latest Octagon Capital Advisors LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Octagon Capital Advisors LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 26 US equity positions with a combined value of $750.61M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-118554 (status: Approved), registered 2020-04-27
  • Regulatory AUM (Form ADV): $1.18B as of 2026-03-20
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 1 hedge funds
  • Website: octagoninvestments.com

Portfolio Structure

  • 26 positions · $750.61M reported value (Q3 2026)
  • Top 10 holdings = 82.5% of reported value
  • Largest position: DNTH (DIANTHUS THERAPEUTICS INC) at 19.8%
  • Average position size: $28.87M

Sector Tilt

  • Health Care 99.6%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 2 new, 1 added, 14 reduced, 3 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 43.5%
Other 56.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.81M $168.03M 26.89%
26.89%
Add
2 2.67M $63.15M 10.11%
10.11%
Add
3 2.37M $47.10M 7.54%
7.54%
Hold
4 1.28M $39.79M 6.37%
6.37%
Hold
5 1.87M $35.68M 5.71%
5.71%
Reduce
6 706.80K $28.53M 4.57%
4.57%
Reduce
7 707.53K $28.06M 4.49%
4.49%
Reduce
8 2.49M $28.01M 4.48%
4.48%
Reduce
9 1.24M $23.66M 3.79%
3.79%
Add
10 414.00K $16.87M 2.70%
2.70%
New
11 2.06M $16.40M 2.62%
2.62%
Add
12 664.58K $13.62M 2.18%
2.18%
Reduce
13 620.00K $13.50M 2.16%
2.16%
Reduce
14 273.29K $11.51M 1.84%
1.84%
Reduce
15 792.95K $10.55M 1.69%
1.69%
Add
16 116.00K $9.68M 1.55%
1.55%
New
17 2.05M $9.31M 1.49%
1.49%
Hold
18 403.69K $9.14M 1.46%
1.46%
Reduce
19 9.19M $8.38M 1.34%
1.34%
Add
20 292.00K $7.26M 1.16%
1.16%
New
21 3.00M $7.08M 1.13%
1.13%
Hold
22 596.61K $5.99M 0.96%
0.96%
New
23 554.00K $5.76M 0.92%
0.92%
Add
24 2.25M $3.60M 0.58%
0.58%
Reduce
25 4.47M $3.53M 0.56%
0.56%
Hold
26 3.80M $2.74M 0.44%
0.44%
New
27 120.00K $2.57M 0.41%
0.41%
New
28 400.00K $1.70M 0.27%
0.27%
Reduce
29 1.00M $1.51M 0.24%
0.24%
New
30 1.78M $981.75K 0.16%
0.16%
Reduce
31 25.00K $738.00K 0.12%
0.12%
New
32 50.00K $456.50K 0.07%
0.07%
New
33 100.00K $105.00K 0.02%
0.02%
New

FAQ

What did Octagon Capital Advisors LP buy in 2023-Q4?

In its 2023-Q4 13F filing, Octagon Capital Advisors LP reported 33 equity positions worth $624.99M in aggregate; its largest disclosed positions were APLS ($168.03M), CBAY ($63.15M), VRNA ($47.10M).

How large is Octagon Capital Advisors LP's portfolio?

Octagon Capital Advisors LP reported $624.99M of long equity holdings across 33 positions as of 2023-Q4. Top-10 holdings account for 76.6% of reported value.

What is Octagon Capital Advisors LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/octagon-capital-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →